Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Third Wave Therapeutics
A single-center study in 25 subjects suffering from moderate to severe insomnia and assess the effectiveness of the intervention. Intervention consists of treatment using a customized audio track delivered via standard commercially-available bone conduction headsets daily for four (4) weeks. Effectiveness is defined by a statistically significant improvement in Insomnia Severity Index (ISI) and Pittsburgh Sleep Quality Index (PSQI) at baseline versus the end of the study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years of age and older
Meets DSM 5 criteria for insomnia disorder
Insomnia Severity Index (ISI) of 15 - 28
You may not be if
Use of sleep medications, sedating or alerting medications or antidepressants in the last 3 months
Diagnosis of any autoimmune disorder or any medical or sleep disorder that could affect sleep
